SLRC logo

SLR INVESTMENT CORP

SLRCNASDAQ
πŸ† #2444 by market capEarnings Nov 3US Equity
$12.84β–Ό $0.10 (βˆ’0.81%)
Live
1hβ–² 0.0%
24hβ–Ό 0.8%
7dβ–² 1.3%
14dβ–Ό 0.5%
30dβ–Ό 0.8%
1yβ–Ό 22.1%
🏦Market Cap
$700M
Small Cap
πŸ“ˆRevenue Growth (YoY)
+24.8%
Healthy
πŸ“ŠGross Margin
66.0%
High
πŸ’΅FCF Margin
73.0%
Strong
βš–οΈP/S Ratio
4.0x
Fair
Otter Score
50
Weak

Trading Snapshot

Day Range
$12.67 – $12.91
52-Week Range
$12.13 – $16.83
Volume
$3.05B
Avg Volume
$2.15B
Shares Outstanding
54.6M
Next Earnings
Oct 20, 2026

Fundamentals Snapshot

Annual Revenue
$220M
Last Q Revenue
$39M
P/E Ratio
9.6
P/S Ratio
4.0x
EPS (TTM)
$1.34
Dividend Yield
11.90%

Why Investors Own SLRC

  • βœ“High-growth profile β€” revenue up +58.1% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 63% gross margin and 6% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$220Mβ–² +51.6% YoY
Gross Margin (TTM)
63.2%β–² +4.5% YoY
Operating Income (TTM)
$36Mβ–² +51.6% YoY
Free Cash Flow (TTM)
$13Mβ–² +51.6% YoY

About SLR INVESTMENT CORP

SLR Investment Corp. is a business development company specializing in secured debt (first lien unitranche and second lien), subordinated (unsecured) debt, minority equity, leveraged buyouts, acquisitions, recapitalizations, general refinancing, growth capital and strategic income-oriented control equity investments in leveraged middle market companies. The fund invests in aerospace and defense; air freight & logistics; asset management; automotive; banking; beverage, food and tobacco; building products; buildings and real estate; broadcasting and entertainment; cargo transport; commercial services and supplies; communications equipment; chemicals, plastics and rubber; containers, packaging and glass; construction & engineering; diversified/conglomerate manufacturing; consumer Finance; distributors; diversified/conglomerate services; diversified financial services; diversified real estate activities; food products; Footwear; Education Services; diversified telecommunications services; electronics; farming and agriculture; finance; grocery; health care equipment and supplies; health care facilities; education and childcare; home and office furnishing, durable consumer products; hotels, motels, inns and gaming; insurance; restaurants, leisure, amusement, and entertainment; leisure equipment tolls and services, media, multiline retail, multi sector holdings; paper and forest products; personal products; professional services, research and consulting services, software; specialty retail; textiles apparel and luxury goods, thrifts and mortgage finance, trading companies and distributors, utilities, and wireless telecommunication services; industrial conglomerates; internet software and services, IT services, machinery; mining, steel, iron, and non-precious metals; oil and gas; personal, food and miscellaneous services; printing and publishing; retail stores; telecommunications; textiles and leather; and utilities. It also invests in life sciences with focus on specialty pharmaceuticals, medical devices, biotech, health Care Providers and services; health Care technology, enabling technologies and tools. The fund primarily invests in United States. The fund’s investments generally range between $5 million and $25million. The fund invests in companies with debt investments between $10 million and $50 million with revenues between $50 million and $1000 million and EBITDA between $15 million and $100 million. It invests in the form of senior secured loans, mezzanine loans, and equity securities. It may also seek investments in thinly traded public companies and also make secondary investments. The fund makes non-control equity investments. It primarily exits within three years of the initial capital commitment.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
50/100

Analyst Price Target

β“˜
Average Target
$15.04
β–² +17.2% Upside
High Target$17.35
Low Target$12.13
Based on 27 analysts

Latest News & Updates